Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > CEA-Leti and partners developing injectable tracer for diagnosing and operating on tumors

Abstract:
CEA-Leti announced today that it and four French partners are developing an injectable tracer that can provide both nuclear imaging in the pre-operative evaluation of tumors and optical imaging during ablation or biopsy.

CEA-Leti and partners developing injectable tracer for diagnosing and operating on tumors

Grenoble, France | Posted on March 16th, 2011

The three-year Nano-ENO project is developing a specific tracer using a patented organic nano-carrier (Lipidot®). To improve its targeting capacities, a peptide molecule that recognizes certain types of cancer will also be grafted to the Lipidots.

In addition to CEA-Leti, the Nano-ENO project partners are:
- A team from the Frédéric Joliot Hospital in Orsay

- AAA, based in Saint-Genis-Pouilly, and specializing in radiopharmaceutical products

- Fluoptics, a CEA-Leti startup based in Grenoble and specializing in fluorescence-imaging systems, and

- VetAgro Sup, based in Marcy-l'Etoile, will oversee the pre-clinical studies on large- animal model (spontaneous tumors in dogs)

When treating cancer, medical professionals often look to several diagnostic tools and surgical aids, including positron emission tomography (PET) scan and fluorescence imaging. A PET scan is a nuclear-imaging procedure that allows doctors to measure the metabolic activity of an organ by injecting a radiotracer and then analyzing the gamma rays that are emitted as the tracer disintegrates.

Fluorescence imaging is a relatively new technology that combines the use of a florescent tracer with near-infrared spectroscopy (NIRS). The resulting real-time images help surgeons obtain cleaner margins during surgery and therefore reduce the risk of recurrence.

The nuclear markers used in a PET scan help provide high-resolution images, while optical contrast agents facilitate the identification of tumor cells in real-time. Combining these imaging technologies makes it possible to confirm that the tumors being operated on correspond to the tumors identified in the pre-operative studies. It also allows for a more thorough procedure to be performed with reduced overall surgical time; not only can the surgeon work more quickly and with greater precision, but the entire operation is streamlined, allowing for a more efficient use of operating rooms and surgical staff.

This project will receive support from the Cancéropôle Lyon Auvergne Rhône Alpes (CLARA) "Preuve de Concept" (Proof of Concept) initiative for three years.

####

About CEA-Leti
EA is a French research and technology organization, with activities in four main areas: energy, information technologies, healthcare technologies and defence and security. Within CEA, the Laboratory for Electronics & Information Technology (CEA-Leti) works with companies in order to increase their competitiveness through technological innovation and transfers. CEA-Leti is focused on micro and nanotechnologies and their applications, from wireless devices and systems, to biology and healthcare or photonics. Nanoelectronics and microsystems (MEMS) are at the core of its activities. As a major player in MINATEC campus, CEA-Leti operates 8,000-m² state-of-the-art clean rooms, on 24/7 mode, on 200mm and 300mm wafer standards. With 1,200 employees, CEA-Leti trains more than 190 Ph.D. students and hosts 200 assignees from partner companies. Strongly committed to the creation of value for the industry, CEA-Leti puts a strong emphasis on intellectual property and owns more than 1,700 patent families.

About CLARA

In the context of a national cancer action plan, CLARA (Cancéropôle Lyon Auvergne Rhône-Alpes) is a government-funded program supporting cancer research in the Rhône-Alpes and Auvergne regions. It brings together academic, clinical, and commercial interests from both regions to contribute to the fight against cancer on the local, national, and international level. Specifically, CLARA fosters partnerships between the public and private sectors and encourages the exchange of technology. With the goal of helping the most patients, Cancéropôle is working to establish the Rhone-Alpes/Auvergne axis as the European authority in cancer research.

www.canceropole-clara.com

About CLARA’s POC Initiative

In 2005, CLARA decided that private finance initiatives were a logical choice for structuring their partnerships between publically funded laboratories and private industry. The “Preuve de Concept” (Proof of Concept) program was the result of this decision. Today, the POC initiative supports 25 projects and represents a budget of over 32 million Euros (23 million of which is provided by the eighteen commercial partners). Four projects have confirmed status, including one product that is currently being marketed in Europe and the United States (EndoControl’s ViKY® system, an ultra compact robotized endoscope positioner).

For more information, please click here

Contacts:
CEA-Leti
Thierry Bosc
+33 4 38 78 31 95


Patrick Boisseau
+33 4 38 78 38 54


Agency
Amélie Ravier
+33 1 58 18 59 30


sarah-lyle dampoux
account supervisor


loomis::group
www.loomisgroup.com
phone +33 (0)1 58 18 59 30

Copyright © CEA-Leti

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Silicene Labs Announces the Launch of Patent-Pending, 2D Materials Composite Index™ : The Initial 2D Materials Composite Index™ for Q2 2014 Is: 857.3; Founders Include World-Renowned Physicist and Seasoned Business and IP Professionals July 24th, 2014

Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Imaging

EPFL Research on the use of AFM based nanoscale IR spectroscopy for the study of single amyloid molecules wins poster competition at Swiss Physics Society meeting July 22nd, 2014

Bruker Awarded Fourth PeakForce Tapping Patent: AFM Mode Uniquely Combines Highest Resolution Imaging and Material Property Mapping July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

"Nanocamera" takes pictures at distances smaller than light's own wavelength: How is it possible to record optically encoded information for distances smaller than the wavelength of light? July 17th, 2014

Chip Technology

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Nanometrics Announces Upcoming Investor Events July 22nd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

NUS scientists use low cost technique to improve properties and functions of nanomaterials: By 'drawing' micropatterns on nanomaterials using a focused laser beam, scientists could modify properties of nanomaterials for effective applications in photonic and optoelectric applicat July 22nd, 2014

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Announcements

Silicene Labs Announces the Launch of Patent-Pending, 2D Materials Composite Index™ : The Initial 2D Materials Composite Index™ for Q2 2014 Is: 857.3; Founders Include World-Renowned Physicist and Seasoned Business and IP Professionals July 24th, 2014

Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Patents/IP/Tech Transfer/Licensing

Silicene Labs Announces the Launch of Patent-Pending, 2D Materials Composite Index™ : The Initial 2D Materials Composite Index™ for Q2 2014 Is: 857.3; Founders Include World-Renowned Physicist and Seasoned Business and IP Professionals July 24th, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Bruker Awarded Fourth PeakForce Tapping Patent: AFM Mode Uniquely Combines Highest Resolution Imaging and Material Property Mapping July 22nd, 2014

Rice's silicon oxide memories catch manufacturers' eye: Use of porous silicon oxide reduces forming voltage, improves manufacturability July 10th, 2014

Research partnerships

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Tiny laser sensor heightens bomb detection sensitivity July 19th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE